BioSpace News Archive

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene and therapies, and consumer health products, today published its first Corporate Responsibility (CR) Report, covering fiscal year 2019.

A common thread in many inflammatory and neurodegenerative diseases, including multiple sclerosis (MS), is damage caused by oxidative stress.

VUNO, a member company of the Born2Global Centre, announced that their AI based screening solution for the fundus, VUNO Med®-Fundus AI™ is approved as a Class III medical device by the Ministry of Food and Drug Safety.

All Canadians have a role to play in helping to protect seniors and medically vulnerable people, who are at greatest risk of severe health complications from COVID-19.

AHF joins the call to demand that countries use compulsory licenses to make COVID-19 medicines available to everyone who needs them

Montgomery County, PA, has teamed up with Real Time Medical Systems to provide 24/7 electronic Infectious Disease Surveillance of nursing facilities in the county, who have volunteered to share their data.

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today the pricing of an underwritten public offering of 2,000,000 shares of its common stock,